The prognostic impact of K-RAS mutations in adult acute myeloid leukemia patients treated with high-dose cytarabine

BACKGROUND: Activating point mutation of the RAS gene has been generally accepted as an oncogenic event in a variety of malignancies. It represents one of the most common genetic alterations in acute myeloid leukemia (AML). However, little is known about its clinical relevance in the treatment outco...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmad, Ebtesam I, Gawish, Heba H, Al Azizi, Nashwa MA, Elhefni, Ashraf M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3143910/
https://www.ncbi.nlm.nih.gov/pubmed/21792317
http://dx.doi.org/10.2147/OTT.S12602

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3143910/
https://www.ncbi.nlm.nih.gov/pubmed/21792317
http://dx.doi.org/10.2147/OTT.S12602

Ejemplares similares